Its architect's daughter has cystic fibrosis—and benefits from a "miracle drug" backed by an agency he's attacking.

Project Vital is a statewide initiative to invest in research, workforce development, and biotech startups, positioning Virginia as a leader in biotechnology. Virginia Tech, Carilion Clinic, and the ...

CVS Health (CVS) reports Q4 earnings on Wed. Stock is down 29.78% in past yr, up 22.72% YTD. Bullish trend but mixed signals. Analysts rate it a Buy with avg price tgt $63.67, potential 17.01% upside.

CVS Health investors will closely examine this week turnaround initiatives spearheaded by new CEO David Joyner and their ...

A team of journalists will produce investigative, data and engagement journalism to serve the people of Missouri, including those affected by its criminal justice system.

As the quarterly earnings season continues, the upcoming week promises a flurry of reports from some of the most influential companies spanning various industries. In the consumer sector, Coca-Cola ...

Analysts on Wall Street project that CVS Health (CVS) will announce quarterly earnings of $0.89 per share in its forthcoming report, representing a decline of 58% year over year. Revenues are ...

The Cabarrus Health Alliance's SUN Project is receiving a grant from Aetna Better Health of North Carolina Inc. to address ...

CVS Health is rolling out a new customer app that aims to make it simpler and more convenient for users to manage health benefits, pharmacy benefits and prescriptions. | CVS Health is rolling out a ...